Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of UB-221 in Healthy Volunteers (clinicaltrials.gov) - Apr 28, 2021 - P1; N=15; Not yet recruiting; Sponsor: UBP Greater China (Shanghai) Co., Ltd; Initiation date: Jun 2020 ➔ Dec 2021
Clinical • Trial initiation date • Chronic Spontaneous Urticaria • Dermatology • Urticaria
|